RooLife ASX announcement

10 July 2020

RooLife & AFT launch Online New Zealand Health Store in China

• RooLife partners with ASX & NZX-listed AFT Pharmaceuticals (ASX:AFP, NZX:AFT) to deliver
New Zealand branded online health & pharmacy store in China
• “Kiwi Health” will be the online marketplace in China for AFT Pharmaceuticals’
high-profile,
well-known and trusted portfolio of health and wellbeing products
• RooLife to provide digital marketing, e-Commerce operation and sales in China
•
“Kiwi Health” will expand RooLife’s and AFT’s revenue streams on Alibaba’s Tmall and
Alipay’s platform with health products expected to be in strong demand
• Three-year contract
expected to deliver revenue of $2.2 million to RooLife based on
services fees and annual sales targets being met
•
Latest agreement takes the value of RooLife’s announced contract wins since March 2020
to $6 million in value, subject to minimum annual sales targets being met for each
respective contract .
•
RooLife Q4 FY2020 unaudited Revenue of $1m+ (up +25% over prior Quarter) during
challenging market conditions
• RooLife is now marketing and selling products in China from Australia, New Zealand, U.S.A.
and United Kingdom
• Third RooLife Tmall store appointment and launch secured in the last 4 months

e-Commerce marketing and Artificial Intelligence (AI) company RooLife Group Ltd (ASX:RLG) (“RooLife”) is
delighted to be appointed by ASX and NZX listed AFT Pharmaceuticals (“AFT”) to launch and operate a
New Zealand branded health & pharmacy store selling key AFT products on Alibaba’s Tmall platform.

The three-year contract expands RooLife’s Alibaba Tmall revenues and provides RooLife a mixture of
monthly service fees and product sales revenue from marketing and selling products within the AFT range.

The contract, which is subject to ongoing sales performance milestones, is expected to deliver total
revenue for the RooLife Group of approximately $2. 2m over a three year period if minimum sales targets,
which are scaled up each year, are met.

The new Kiwi Health store will market and sell a range of health and well-being products online in China
leveraging the strong brand awareness of AFT’s product range using the “Kiwi’s thinking about health”
branding.


Kiwi Health Tmall Store Launching on Alibaba – “Kiwi’s thinking about health”

AFT Founder and CEO, Dr Hartley Atkinson says that he is very pleased to further extend the company’s
offering to consumers via Online China, “With a population of over 1.4 billion
1
(2020), and with our
products already having a strong following by the local Chinese consumer living in New Zealand, we believe
that a Tmall flagship store along with amplifying our online presence in China, represents great potential
for our health and well-being portfolio’s future growth,” said Dr Atkinson.

RooLife Managing Director, Bryan Carr commented, “Working with AFT Pharmaceuticals to market and sell
their well-known, trusted portfolio of health and wellbeing products in the Chinese market under the Kiwi
Health banner is an attractive growth opportunity for RooLife.

We have seen the successes achieved by large Australian and NZ based pharmacy chains online in China
and we are excited by the opportunity available with AFT Pharmaceuticals’ range of products, leveraging
the high regard for New Zealand and its products with Chinese shoppers.”

The latest contract is expected to contribute to the continued revenue growth RooLife has achieved in the
last 18 months with growth of 490% achieved in FY19 and 380% achieved in FY20.

Continuing to build on the strong revenue base achieved in Financial Year 2020, RooLife has announced
three new contract wins totalling $6 million in revenue expected this year and over the next two years,
subject to the respective minimum sales performance milestones being met.

RooLife Strong Year-on-Year Revenue Growth
(*Based on minimum sales performance milestones)

RooLife has achieved strong revenue growth this year with unaudited revenue of over $1 million for the
Quarter ended 30 June 2020 and we are seeing solid demand for health and well-being products such as
those provided by AFT and we expect this new agreement to contribute to further sales growth this
financial year.

The RooLife platform provides an international gateway for products and services for companies wishing
to enter the China market. RooLife is now representing and driving sales for a growing number of quality
products and brand names into China for companies from Australia, New Zealand, U.S.A and the United
Kingdom.”

ENDS

1. Source: www.worldometers.info/world-population/china-population

Issued by: RooLife Group Ltd
Authorised by: The Board of RooLife Group Ltd

For further information, please visit the RooLife website at www.roolifegroup.com.au and
www.aftpharm.co.nz or contact:

Bryan Carr
Managing Director
Ph: +61 8 6444 1702
Email: ir@roolifegroup.com.au

Peter Nesveda
Corporate Affairs & International
Investor Relations
Ph: +61 412 357 375
peter@intuitiveaustralia.com.au

Sarah Lenard – Advisir
Investor Relations/Media Contact
Telephone: +61 432 332 905
Email: sarah.lenard@advisir.com.au


About RooLife Group Ltd (ASX:RLG)
www.roolifegroup.com.au
The RooLife Group of companies provides fully integrated digital marketing and customer acquisition services focusing on
driving online sales of products and services for its clients. Powered by the Group’s hyper personalisation and profiling
Artificial Intelligence System, RooLife provides personalised real-time, targeted marketing. With a key focus on driving sales
in Australia and China the company’s online e-Commerce marketplace assists businesses to sell directly to Chinese consumers
and accept payment via the WeChat and Al ipay mobile payments platforms. RooLife’s key positioning is about knowing and
remaining connected with Chinese consumers, allowing brands to continually sell products to Chinese consumers based on
their profiles and purchasing behaviours.
New Contract Revenue FY21+
*

Nurea Beauty $1.3m
Colab $2.5m
Kiwi Health $2.2m
TOTAL $6.0m

About AFT Pharmaceuticals (ASX:AFP, NZX:AFT)
www.aftpharm.com
AFT Pharmaceuticals are a growing multinational pharmaceutical company that develops, markets and distributes a broad
portfolio of pharmaceutical products across a wide range of therapeutic categories which are distributed across all major
pharmaceutical distribution channels: over-the-counter, prescription and hospital. AFT's product portfolio comprises both
proprietary and in-licensed products, and includes patented, branded and generic drugs.